APPLICATIONS have opened for the final round of Advancing Practice for 2018, as the program announced final credentialing post-nominals.
Several members of the Advancing Practice Advisory Board highlighted Australia's progress by presenting research on the development and realisation of Advanced Practice credentialing in Australia, at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences (FIP Congress) 2018 in Glasgow, UK.
Recently, the advisory board confirmed the three levels of postnominals to be confirmed to credentialed program participants: AdvPP(I), AdvPP(II) and Adv. Prac. Pharm.
Advisory Board chair Associate Professor Ian Coombes says the postnominals are an important aspect of participants' credentialing outcome.
"Being able to quickly and concisely convey credentialing at Stage I Advancing Practice, Stage II Advancing Practice or as an Advanced Practice Pharmacist is a confident signal to the Australian community that the profession is practising at a high level.
"The FIP's Advanced Practice and Specialisation in Pharmacy: Global Report 2015 showed 20 countries and territories indicated the use of a formal post-nominal for individuals that matches professional recognition of specialisation and/or advanced practice, so it is fitting that Advancing Practice similarly recognises all levels of achievement as part of the Australian program," Coombes concluded.
Professors Debbie Rigby, Kirstie Galbraith, Debra Rowett, and Lisa Nissen, Dr Catherine Duggan, Dr Chris Freeman, Sam Turner, Leanne Wells and Elise Apolloni are current advisory board members.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Sep 18
